Global Partnership Against the Spread of Weapons and Materials of Mass Destruction - September 2020 Update
On behalf of the 31 members of the Global Partnership Against the Spread of Weapons and Materials of Mass Destruction(the Global Partnership), we are pleased to issue this inaugural newsletter. The Newsletter will be circulated on a quarterly basis and will provide updates on Global Partnership projects and resources, affiliated events and key developments related to preventing the proliferation of chemical, biological, radiological, and nuclear (CBRN) weapons and related materials.
It is a fitting tribute that this newsletter is launched on the 19th anniversary of the terrorist attacks of September 11, 2001 in the United States. The tragic events of that day were the stimulus for the establishment of the Global Partnership at the Kananaskis Summit,(2002), where Leaders recognised that “terrorists are prepared to use any means to cause terror and inflict appalling casualties on innocent people” and committed “to prevent terrorists, or those that harbour them, from acquiring or developing nuclear, chemical, radiological and biological weapons; missiles; and related materials, equipment and technology”.
More than 18 years later the G7-led Global Partnership has grown to include 30 active member countries and the European Union, has delivered more than US$25 billion in tangible threat-reduction programming and continues to lead international efforts to mitigate all manner of CBRN threats around the world.
Did you know:
Biosecurity programming implemented by GP partners, which is guided by the Partnership’s Biosecurity Deliverables, is meaningfully supporting the global response to COVID-19.
In response to the use of a chemical nerve-agent to poison Russian Opposition Leader Alexei Navalny, G7 Foreign Ministers issued a statement on 8 September that underscored that “the use of chemical weapons, anywhere, anytime, by anybody, under any circumstances whatsoever, is unacceptable and contravenes the international norms prohibiting the use of such weapons”. Preventing and Responding to Chemical Weapons Useis a top Global Partnership priority.
In 2020, the Global Partnership’s Nuclear and Radiological Security Working Group has helped to coordinate over CA$7.4 million in Canadian-funded programming initiatives in such diverse areas as strengthening physical protection of radioactive diagnostic and treatment materials at hospitals, and the prevention of illicit trafficking of nuclear or radiological materials through airports and contested territories.
The GP has taken the plunge and joined twitterverse! Follow us at @GPWMDOfficial to stay on top of everything we are doing to make the world a safer place by #CounteringWMD.
To advance the Global Partnership priority of “strengthening global mechanisms and capabilities to respond to the deliberate use of biological agents”, GP partners are supporting the Implementation Support Unit of the Biological and Toxin Weapons Convention (BTWC) to enhance Article VII of the BTWC through the development of an International Bio-Emergency Management Framework for Deliberate Events.
The United Kingdom Contributed £800,000 to Support OPCW Activities, including the Trust Fund for Syria Missions at the OPCW, the Trust Fund for Training, the Trust Fund for Security and Business Continuity (cybersecurity), and the Trust Fund for the Implementation of Article X of the Chemical Weapons Convention.
With support from Global Partnership members, the 6th World One Health Congress will be convened (virtually) from 30 October-3 November 2020. The Congress will include numerous Global Partnership related and relevant sessions, including:
Biological Threat Reduction and Control of Biological agents (31 October, 16:00 CET);
Risk Reduction Frameworks/Global Health Security (2 November, 16:00 CET);
Biological Threat Modelling and Risk Evaluation Using Big Data (1 November, 14:00 CET); and
a Special Partner Session organized by the WHO’s Health Security Interface (31 October, 12:00 CET).